Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema
Moataz F ElsawyOphthalmology Department, Faculty of Medicine, Menofia University, Menofia, EgyptObjectives: To evaluate the outcome of vitreolysis using intravitreal autologous plasmin (IAP) injection as a sole therapeutic modality for patients with diffuse diabetic macular edema in comparison to tr...
Guardado en:
Autor principal: | Elsawy MF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b37441dec194e0689afba4ce4423196 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel PU, et al.
Publicado: (2015) -
Intravitreal gas injection for the treatment of diabetic macular edema
por: McHugh D, et al.
Publicado: (2011) -
Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim M, et al.
Publicado: (2013) -
Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon S, et al.
Publicado: (2014) -
Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema
por: Saeed AM
Publicado: (2013)